Hypereosinophilic Syndrome - 25 Studies Found
Terminated |
: A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2005-09-13 : Drug: imatinib mesylate Other Name: Gleevec/Glivec |
Completed |
: Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2001-06-15 : Drug: SCH55700 |
Terminated |
: Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2004-11-22 : Drug: mepolizumab Study Drug |
Recruiting |
: Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) : Hypereosinophilic Syndrome : 2016-07-14 :
|
Recruiting |
: Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2002-08-24 : Drug: Imatinib Mesylate Imatinib is a tyrosine kinase inhibitor that selectively inhibits bcr-abl, c-kit |
Active, not recruiting |
: Identification of New Markers in the Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2012-10-22 : Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms |
Active, not recruiting |
: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2014-03-14 : Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in |
Recruiting |
: Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2014-04-03 :
|
Completed |
: Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) :
: 2004-07-07 : Drug: mepolizumab |
Withdrawn |
: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome :
: 2005-09-28 : Drug: Gleevec |